EPS for Kenon Holdings Ltd (KEN) Expected At $0.00, Sciclone Pharmaceuticals (SCLN) Shorts Up By 3.96%

May 16, 2017 - By Winifred Garcia

Sciclone Pharmaceuticals (NASDAQ:SCLN) had an increase of 3.96% in short interest. SCLN’s SI was 1.48M shares in May as released by FINRA. Its up 3.96% from 1.42 million shares previously. With 276,200 avg volume, 5 days are for Sciclone Pharmaceuticals (NASDAQ:SCLN)’s short sellers to cover SCLN’s short positions. The SI to Sciclone Pharmaceuticals’s float is 3.22%. It is 0.00% or $0 reaching $9.75 per share. It is down 5.73% since October 6, 2016 and is downtrending. It has underperformed by 16.38% the S&P500.

Analysts expect Kenon Holdings Ltd (NYSE:KEN) to report $0.00 EPS on June, 14. It is down 9.46% since October 6, 2016 and is uptrending. It has underperformed by 1.19% the S&P500.

Kenon Holdings Ltd. is a holding company that operates primarily growth-oriented businesses. The company has market cap of $667.50 million. The Company’s divisions include I.C. It currently has negative earnings. Power Asia Development Ltd , Qoros Automotive Co., Ltd. (Qoros) and Other.

Since November 21, 2016, it had 0 buys, and 13 selling transactions for $3.40 million activity. $715,179 worth of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) shares were sold by Blobel Friedhelm. The insider Zhao Hong sold $28,800. Another trade for 1,000 shares valued at $9,600 was made by Xie Lan on Wednesday, March 15.

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.14, from 1.34 in 2016Q3. It dived, as 20 investors sold SciClone Pharmaceuticals, Inc. shares while 44 reduced holdings. 29 funds opened positions while 48 raised stakes. 34.89 million shares or 8.90% less from 38.30 million shares in 2016Q3 were reported. Comml Bank Of America De reported 42,769 shares. Strs Ohio invested 0% of its portfolio in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). First Tru Advsr L P stated it has 0% of its portfolio in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). Capstone Invest Advisors Ltd Limited Liability Company has 20,640 shares. Balyasny Asset Mgmt Ltd Liability Corporation has 0% invested in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) for 18,705 shares. Mason Street Lc stated it has 11,156 shares or 0% of all its holdings. Blackrock Grp Inc stated it has 0% in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN). 107,612 are held by Parametric Portfolio Assoc Ltd Limited Liability Company. Ubs Asset Mgmt Americas, Illinois-based fund reported 11,297 shares. Public Sector Pension Board invested in 34,500 shares or 0% of the stock. Eqis Mngmt owns 33,722 shares. Barclays Public Ltd Liability Corp holds 142,130 shares. Ny State Common Retirement Fund holds 0% or 55,000 shares in its portfolio. California State Teachers Retirement System holds 103,384 shares or 0% of its portfolio. Geode Capital Management Limited Liability Co has 396,728 shares for 0% of their portfolio.

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. The company has market cap of $506.99 million. The Company’s product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. It has a 12.98 P/E ratio. The Company’s business is focused primarily in the People’s Republic of China.